Government Survey Could Lead To New Round Of Drug Price Cuts In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Survey, slated to wrap up by the end of June, is being carried out by China’s provincial food and drug regulators and price-setting agencies.
You may also be interested in...
China SFDA Seeks Public Comment On Change To Proposed Definition Of “New” Drugs
Agency’s draft drug registration rules propose to eliminate China’s fast track approval process for certain types of drugs, including AIDS and oncologics.